IIM
ALXN
Intact Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,400
| Closed | -$687K | – | 261 |
|
|
2020
Q4 | $687K | Sell |
4,400
-3,400
| -44% | -$531K | 0.02% | 212 |
|
|
2020
Q3 | $892K | Hold |
7,800
| – | – | 0.03% | 189 |
|
|
2020
Q2 | $874K | Sell |
7,800
-1,000
| -11% | -$112K | 0.03% | 191 |
|
|
2020
Q1 | $790K | Buy |
8,800
+1,600
| +22% | +$144K | 0.03% | 182 |
|
|
2019
Q4 | $778K | Buy |
7,200
+3,600
| +100% | +$389K | 0.03% | 195 |
|
|
2019
Q3 | $353K | Hold |
3,600
| – | – | 0.01% | 211 |
|
|
2019
Q2 | $472K | Hold |
3,600
| – | – | 0.02% | 196 |
|
|
2019
Q1 | $487K | Hold |
3,600
| – | – | 0.02% | 191 |
|
|
2018
Q4 | $351K | Sell |
3,600
-1,400
| -28% | -$137K | 0.01% | 192 |
|
|
2018
Q3 | $695K | Sell |
5,000
-300
| -6% | -$41.7K | 0.02% | 173 |
|
|
2018
Q2 | $658K | Hold |
5,300
| – | – | 0.02% | 169 |
|
|
2018
Q1 | $591K | Sell |
5,300
-200
| -4% | -$22.3K | 0.02% | 168 |
|
|
2017
Q4 | $658K | Buy |
5,500
+400
| +8% | +$47.9K | 0.03% | 140 |
|
|
2017
Q3 | $715K | Sell |
5,100
-2,100
| -29% | -$294K | 0.03% | 142 |
|
|
2017
Q2 | $876K | Buy |
7,200
+1,900
| +36% | +$231K | 0.04% | 134 |
|
|
2017
Q1 | $643K | Sell |
5,300
-1,300
| -20% | -$158K | 0.03% | 147 |
|
|
2016
Q4 | $808K | Buy |
6,600
+4,700
| +247% | +$575K | 0.03% | 165 |
|
|
2016
Q3 | $233K | Buy |
+1,900
| New | +$233K | 0.01% | 256 |
|
|
2016
Q2 | – | Sell |
-1,500
| Closed | -$209K | – | 291 |
|
|
2016
Q1 | $209K | Buy |
1,500
+300
| +25% | +$41.8K | 0.01% | 261 |
|
|
2015
Q4 | $229K | Buy |
+1,200
| New | +$229K | 0.01% | 231 |
|